Back to News
Market Impact: 0.4
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook
Source: zacks.com
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
Elevance Health beat its Q3 EPS estimate by 50% as Carelon grew despite declining medical membership. The company also raised its 2026 underlying earnings baseline to $26.75.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
ELV0.75
More News
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- CoreWeave’s market confidence erodes as bond yields spike and stock sinks
- Why the stock market’s fragile calm faces a major test starting Friday
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal
- Why is Tesla stock falling after-hours today?